Simon Witty
Lawyers
Filters
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
New Energy One Acquisition £175 million IPO
Shares of the SPAC are listed on the London Stock Exchange
LivaNova $345 million equity offering
We advised the underwriters on the SEC-registered offering
Royalty Pharma $1.3 billion senior notes offering
We advised Royalty Pharma on its SEC-registered investment-grade notes offering, including $600 million in social bonds
Sixjoy Hong Kong £919 million offer for Sumo Group
We are advising Tencent on the recommended cash offer by its indirect subsidiary
Membership Collective Group $420 million IPO
We advised the underwriters on the IPO and NYSE listing
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Immunocore $297 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
Abcam $180 million U.S. IPO of ADSs
Davis Polk advised the representatives of the several underwriters in connection with Abcam plc’s $180 million U.S. initial public offering of 10,287,000 American depositary shares…
Royalty Pharma $728 million secondary offering
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $728 million secondary offering of 17,343,037 of its Class A ordinary shares by certain selling…